The Board of Advisors are expert business leaders who offer advise and assistance on strategic initiatives targeted at growing the Jessie Rees Foundation.
Robert I. Bonar Jr., Dr. H.A. – Member, Board of Advisors
Bob Bonar is currently Executive Vice President, Physician Enterprise, President/CEO Seton Family of Hospitals and CEO Dell Children’s Medical Center of Central Texas. He leads development of the infrastructure needs for all Seton Family physician organizations, including management of physician practice plans, creation and implementation of new physician services and oversight of long-term strategic plans including physicians in addition to leading Dell Children’s.
He began his career in healthcare during the 1970s as a hospital-based street and flight paramedic. He earned master’s degrees in education administration and healthcare administration and served as director of Emergency and Trauma Services and the air ambulance system at West Virginia University Hospitals in Morgantown.
Ron A. Andrews – Member, Board of Advisors
As President, Medical Sciences at Life Technologies, Andrews will apply his expertise to expand Life’s presence in the diagnostics and personalized medicine space through strategies including short and long term partnerships.
“Ronnie is one of the most dynamic and respected leaders in the diagnostic industry,” said Gregory T. Lucier, Life Technologies’ Chairman and Chief Executive Officer. “He adds to Life’s management team a deep expertise in commercializing diagnostics, particularly in the molecular domain.”
Andrews’ accomplishments in diagnostics include:
- GE Healthcare, As CEO Clarinet and Segment Leader, GE Molecular Diagnostics, Andrews led integration of Clarient, maintaining 20 per cent annual growth and establishing a strategic plan to expand GE’s presence in oncology diagnostics.
- Clarient, As CEO, Andrews transformed former ChromaVision into a comprehensive cancer diagnostics company, leading the organization from $6MM in annual revenue to $120MM. He raised more than $50MM in capital to fund growth, obtained exclusive licenses for oncology biomarkers and successfully launched new molecular tests for cancers, including leukemia and melanoma. GE Healthcare purchased Clarient in December of 2010 for $587MM, a 5.8-fold multiple of sales.
- Roche Molecular Diagnostics, As Senior Vice President, Global Marketing and Commercial Business Operations, Andrews directed annual growth rates of 20 per cent and was instrumental in building Roche’s HIV molecular testing business, establishing molecular as the gold standard for infectious disease testing.
“Life has multiple platforms that can be leveraged in the diagnostics market in the near term,” said Andrews. “It was the disruptive Ion Torrent technology, however, that tipped the scale for me to come on board.”
Ron earned a Bachelor’s degree in Biology and Chemistry from Spartanburg, SC-based Wofford College in 1981 and has participated extensively in the executive development programs at both Roche and Abbott Labs. He currently lives with his wife and three children in Coto de Caza, CA.
Dick Allen – Member, Board of Advisors
Dick has over 39 years experience in the health care industry, both as an operating executive and as an angel investor/board member. He started his career at Baxter Healthcare, holding domestic and international positions in both finance and operations during his 10 year stint there. After leaving Baxter, Dick co-founded Caremark, a venture capital-backed pioneer of IV infusion therapy delivered in the home. He headed the finance, operations, and administration functions of the company at various times in its period of rapid growth and was instrumental in helping to lead a successful IPO just three years after the company’s founding. Since Caremark’s sale to Baxter in 1987, Dick has been President of DIMA Ventures, a privately-held firm that provides seed capital and board support for start-up companies in the medical device and health care IT markets. In this capacity, he has been a founder, board member, or early-stage private investor in more than a dozen companies. He co-founded Pyxis Corporation, a manufacturer and marketer of hospital-based automated prescription drug storage and dispensing devices, and he served on the executive committee of the Board of Directors until the sale of the company for almost $1 billion to Cardinal Health in 1996.
Dick held the position of Lecturer in Management at the Stanford Graduate School of Business from 1989 to 1993. He returned to Stanford in 2004 where he is presently teaching a course entitled Managing Growing Enterprises. Dick is a past Chairman of the Board of Hoag Memorial Hospital Presbyterian, and he continues to serve as a board member for the hospital. He is also a past Chairman of the Board of Directors of the Orange County Business Council and a past recipient of the Director of the Year award from the Orange County Forum for Corporate Directors. He is on the Board of Directors of the Orange County Community Foundation, the M.I.N.D. Institute, and several privately held health care companies.
Dick received his BS degree (cum laude) from Yale University and an MBA from Stanford Graduate School of Business. He was born and raised in Sioux City, Iowa, and has been married to his wife Mary for 41 years. They are both active in the Orange County chapter of the Juvenile Diabetes Research Foundation. They live in Newport Beach, California, and have two grown children and two grandchildren.
David Crockett – Member, Board of Advisors
Mr. Crockett is well-known in the bio-medical device industry, and represents industry leaders with diverse technologies, including internet communications, silicon wafer processing, and virtual reality systems. His technical expertise spans many disciplines, including nuclear power, electronics and electrical engineering, hydraulics, pumps and motors, medical devices, software, communications, silicon wafer processing, and nitinol and shape memory materials. Mr. Crockett draws on this vast technical experience to provide specialized patent counseling dealing with multi-disciplinary technology issues.
Before becoming an attorney, Mr. Crockett was a Lieutenant in the United States Navy on board the fast attack submarine USS La Jolla (SSN 701). Mr. Crockett was also associated with Lyon & Lyon before forming Crockett & Crockett.